Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikash Reebye

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nucleic Acid Therapeutics|July 27, 2022
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic SyndromePinelopi Andrikakou, Vikash Reebye, Daniel Vasconcelos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2016
Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In VivoSorah Yoon, Kai-Wen Huang, Vikash Reebye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2019
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized MiceJiehua Zhou, Haitang Li, Xin Xia, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthSorah Yoon, Kai-Wen Huang, Vikash Reebye, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral BloodPaul J Mintz, Pål Sætrom, Vikash Reebye, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Molecular Therapy. Nucleic Acids|December 27, 2019
Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic ProfileKai-Wen Huang, Vikash Reebye, Katherine Czysz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Exploiting human CD34+ stem cell-conditioned medium for tissue repairPaul J Mintz, Kai-Wen Huang, Vikash Reebye, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivoVikash Reebye, Pål Sætrom, Paul J Mintz, et al.
Frontiers in Medicine|May 25, 2026
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-HVikash Reebye, Konstantina Skourti-Stathaki, Konstantinos Vanezis, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nucleic Acid Therapeutics|July 27, 2022
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic SyndromePinelopi Andrikakou, Vikash Reebye, Daniel Vasconcelos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2016
Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In VivoSorah Yoon, Kai-Wen Huang, Vikash Reebye, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 11, 2019
Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized MiceJiehua Zhou, Haitang Li, Xin Xia, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell GrowthSorah Yoon, Kai-Wen Huang, Vikash Reebye, et al.
Molecular Therapy. Nucleic Acids|January 25, 2013
MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral BloodPaul J Mintz, Pål Sætrom, Vikash Reebye, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Molecular Therapy. Nucleic Acids|December 27, 2019
Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic ProfileKai-Wen Huang, Vikash Reebye, Katherine Czysz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2013
Exploiting human CD34+ stem cell-conditioned medium for tissue repairPaul J Mintz, Kai-Wen Huang, Vikash Reebye, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivoVikash Reebye, Pål Sætrom, Paul J Mintz, et al.
Frontiers in Medicine|May 25, 2026
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-HVikash Reebye, Konstantina Skourti-Stathaki, Konstantinos Vanezis, et al.
Pageof 4